FDA clear Ethicon's vessel harvest device:
This article was originally published in Clinica
Johnson & Johnson company Ethicon has gained US FDA 510(k) clearance for its Clearglide precision bipolar device, which is to be used with the company's minimally invasive system for harvesting saphenous veins used in heart bypass surgery. The product is a sterile, single-patient-use instrument that clamps, coagulates and transects tissue with an integral knife blade. It also uses a patented offset electrode technology, which the company claims can reduce injury to the vessel and surrounding tissue. The device will be offered through Ethicon's Cardiovations division and will complement the company's Clearglide Accel endoscopic harvest system.